Navigation Links
SkilaMederi and Qforma Announce Merger

MORRIS PLAINS, N.J. and SANTA FE, N.M., June 6, 2013 /PRNewswire/ -- SkilaMederi, a global life-sciences social analytics strategic solutions and launch optimization provider, and Qforma, a leading provider of advanced analytics and predictive technologies for the life sciences industry, announce their merger. BelHealth Investment Partners, a healthcare private equity firm and majority owner of SkilaMederi, will support the merger with an additional equity investment.

(Logo: )

SkilaMederi, in business since 1995, is a leading provider of global product launch optimization and stakeholder engagement insight that drive measurable value for life sciences companies. SkilaMederi's CrowdLink™ stakeholder analytics platform and iLaunch™ intelligent launch optimization services are used around the globe by industry-leading medical, marketing, market access and sales teams at pharmaceutical, biotechnology and medical device companies.

Qforma, formed in 2000 from technology initially developed at Los Alamos National Laboratory, empowers its healthcare customers with actionable insights, quantified metrics, and timely alerts to impending change. Qforma has established itself as the leader in Community Opinion Leader mapping, which is critical as healthcare companies continue to educate physicians about new therapies in a resource-challenged environment.

NewCo will be called Qforma and will emerge as a leading provider of healthcare data analytics. It will focus on social analytics, stakeholder engagement insights, predictive modeling and launch optimization. As the health care industry evolves, decision makers increasingly rely on real-time actionable intelligence. The combined company is uniquely positioned to provide insights from thousands of local experts in any given disease or condition, Accountable Care Organizations (ACO), Managed Care Organizations, healthcare provider groups, integrated health systems and hospitals.

The key strategic benefits of the merger include:

  • Comprehensive product offering: The combined company will have the most unique and broad product offering that will help pharmaceutical, biotechnology and medical device companies target their marketing efforts on a global, national and local level.
  • Leader in social network analytics: Social network data and analysis is transforming marketing tactics and NewCo is well-positioned to capitalize on this growing trend.
  • Cross marketing opportunities: The two companies have a diverse customer base without much overlap. This provides immediate cross-selling opportunities.
  • Global presence: Qforma will have six offices including four in the US and two in Europe enabling the company to effectively and efficiently service its customers.

Kilian Weiss , Chief Executive Officer of SkilaMederi, will lead the combined organization. "The merger allows us to create a unique combination of social analytics with real world healthcare data and provide the life sciences industry with unparalleled, actionable intelligence. I am very impressed with the capabilities of the Qforma software team. Santa Fe is well-known for complex research and development and the combined company can benefit from this pool of technical expertise."

Roger D. Jones , PhD, Co-Founder of Qforma and director of NewCo said, "The merger allows us to bring non-traditional data sets such as social media into our analysis. We have been looking to add social media data to our capability for some time, and to merge with SkilaMederi, the leader in this area, provides our customers a tremendous opportunity. We could not have chosen a better partner in terms of innovation and commitment to customers. We will utilize SkilaMederi's global presence to bring exciting products to new clients worldwide." Roger added, "Working with Kilian and BelHealth has been a pleasure."

"BelHealth's strategy is to create a leading provider in the fragmented pharmaceutical analytics market and the merger brings us closer to our goal. We have evaluated several acquisition prospects for SkilaMederi over the past year and Qforma is clearly the perfect fit. We are very excited about NewCo's positioning and opportunity" said, Inder Tallur , Managing Director of BelHealth Investment Partners, L.P. "The combination of traditional pharmaceutical data analytics, combined with social media sentiment and network analysis, is a major step forward for the healthcare industry, and we are proud to lead the way."

NewCo will have a global presence with facilities in Frankfurt, Germany; Lviv, Ukraine; Santa Fe, New Mexico; Princeton, New Jersey; Chicago, Illinois and headquarters in Morris Plains, New Jersey.

About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies we believe would benefit from our vast operating and private equity experience. The firm typically invests $10-25 million per platform company across three healthcare segments: Services, Information Technology and Products & Distribution. Applying an active, hands-on approach, BelHealth utilizes its experience to support management, drive revenue and profit growth and achieve superior returns for its investors and partners.

For further information, please visit  

SOURCE SkilaMederi
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SkilaMederi Names Ray Joske as Chief Commercial Officer
2. Qforma Chief Technologist Honored as One of PharmaVOICE Magazines "100 Most Inspiring People in the Life Sciences"
3. Qforma Appoints New VP, Business Development
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
6. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
11. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
Post Your Comments:
(Date:11/30/2015)... 2015  Precision Image Analysis Inc. (PIA), a ... announce a dramatic expansion of its capabilities as ... its ISO-9001:2008 certification for its Quality Management System, ... protocols and procedures. This expansion enables PIA to ... Core Lab services include design and optimization of ...
(Date:11/30/2015)... Mexico Healthcare and Life Sciences Report 2015 ... . --> Pharmaboardroom releases its new 98-page Mexico ... America , a country of over 122 million people. ... 122 million people. --> It offers companies, investors, policymakers, ... insights into the second largest pharma and healthcare market in ...
(Date:11/30/2015)... AVIV, Israel , November 30, 2015 ... ) ("Elbit" or the "Company") announced today that it was ... of Food and Drug Safety (MFDS) has approved its ... disorders. --> --> ... a non-invasive treatment alternative that combines two technologies: Focused ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 2015 , ... Since its inception, Seniors Guide has been ... living and all other retirement options. Support for issues surrounding the senior community ... top priority. , So it’s no surprise that every November, Seniors Guide ...
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb – Kreithen ... plastic surgery practices in Florida, is proud to announce that Dr. Joshua Kreithen, ... giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is a global ...
(Date:11/30/2015)... ... , ... Sikka Software announced today that they are showcasing the Sikka Software ... complex business decisions by providing the tools and information they need to grow their ... procedures customized by zip code. , The Sikka Software Ecosystem includes over 32 ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... verified that their Vasont Universal Integrator (VUI) extension unites with Syncro Soft’s latest ... managing content as a continuous process with the latest release of oXygen® XML ...
(Date:11/30/2015)... Phoenixville, PA (PRWEB) , ... November 30, 2015 ... ... all of the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development ... by utilizing the programming and technical experience available within DataTrade to extend the ...
Breaking Medicine News(10 mins):